154 related articles for article (PubMed ID: 18234057)
1. Development of time-resolved immunofluorometric assays for vascular endothelial growth factor and application on plasma of patients with gastric tumours.
Sheng SL; Bao SH; Huang G; Wang LM
Clin Exp Immunol; 2008 Mar; 151(3):459-66. PubMed ID: 18234057
[TBL] [Abstract][Full Text] [Related]
2. Development of time-resolved immunofluorometric assays for CA 72-4 and application in sera of patients with gastric tumors.
Sheng SL; Wang Q; Huang G
Clin Chim Acta; 2007 May; 380(1-2):106-11. PubMed ID: 17321510
[TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance.
Xu T; Chen D
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):329-31, 355. PubMed ID: 16961284
[TBL] [Abstract][Full Text] [Related]
4. Time-resolved immunofluorometric assay (TR-IFMA) for the detection of the schistosome circulating anodic antigen.
de Jonge N; Boerman OC; Deelder AM
Trans R Soc Trop Med Hyg; 1989; 83(5):659-63. PubMed ID: 2515632
[TBL] [Abstract][Full Text] [Related]
5. Determination of human tumour necrosis factor-alpha (TNF-alpha) by time-resolved immunofluorometric assay.
Turpeinen U; Stenman UH
Scand J Clin Lab Invest; 1994 Oct; 54(6):475-83. PubMed ID: 7809581
[TBL] [Abstract][Full Text] [Related]
6. Detection of Hepatitis B Virus Large Surface Protein Using a Time-Resolved Immunofluorometric Assay.
Hu Z; Li M; Liu J; Yu L; Xue Y; Chen Y
J Clin Lab Anal; 2015 Nov; 29(6):498-504. PubMed ID: 25277704
[TBL] [Abstract][Full Text] [Related]
7. Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer.
Wang TB; Deng MH; Qiu WS; Dong WG
World J Gastroenterol; 2007 Mar; 13(12):1794-7; discussion 1797-8. PubMed ID: 17465468
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer.
Hyodo I; Doi T; Endo H; Hosokawa Y; Nishikawa Y; Tanimizu M; Jinno K; Kotani Y
Eur J Cancer; 1998 Dec; 34(13):2041-5. PubMed ID: 10070308
[TBL] [Abstract][Full Text] [Related]
9. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Zbar A; Kouraklis G; Simopoulos C; Karatzas G
Ann Surg; 2002 Jul; 236(1):37-42. PubMed ID: 12131083
[TBL] [Abstract][Full Text] [Related]
10. Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.
Tsirlis TD; Kostakis A; Papastratis G; Masselou K; Vlachos I; Papachristodoulou A; Nikiteas NI
J Surg Oncol; 2010 Nov; 102(6):699-703. PubMed ID: 20672317
[TBL] [Abstract][Full Text] [Related]
11. Optimization of a time-resolved immunofluorometric assay for tumor-associated trypsin inhibitor (TATI) using the streptavidin-biotin system.
Osman S; Turpeinen U; Itkonen O; Stenman UH
J Immunol Methods; 1993 May; 161(1):97-106. PubMed ID: 8486933
[TBL] [Abstract][Full Text] [Related]
12. Potential prognostic value of circulating levels of vascular endothelial growth factor-A in patients with gastric cancer.
Ding S; Lin S; Dong X; Yang X; Qu H; Huang S; Liu W; Zhou L; Liu D
In Vivo; 2005; 19(4):793-5. PubMed ID: 15999551
[TBL] [Abstract][Full Text] [Related]
13. Analytical and clinical validation of a time-resolved immunofluorometric assay (TR-IFMA) for canine C-reactive protein in serum.
Parra MD; Tuomola M; Cabezas-Herrera J; Cerón JJ
Vet Res Commun; 2006 Feb; 30(2):113-26. PubMed ID: 16400598
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
15. Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer.
Villarejo-Campos P; Padilla-Valverde D; Martin RM; Menéndez-Sánchez P; Cubo-Cintas T; Bondia-Navarro JA; Fernández JM
Clin Transl Oncol; 2013 Apr; 15(4):265-70. PubMed ID: 22855190
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Serum Vascular Endothelial Growth Factor, Pigment Epithelium-Derived Factor, Tumor Necrosis Factor Alpha, and Progranulin Levels in Patients with Gastric Cancer and Gastric Precancerous Lesions.
Aksoy EK; Akpınar MY; Doğan Ö; Göktaş Z; Sapmaz FP; Şimşek GG; Uzman M; Nazlıgül Y
J Gastrointest Cancer; 2019 Sep; 50(3):537-542. PubMed ID: 31089953
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.
Oh SY; Kwon HC; Kim SH; Jang JS; Kim MC; Kim KH; Han JY; Kim CO; Kim SJ; Jeong JS; Kim HJ
BMC Cancer; 2008 May; 8():123. PubMed ID: 18452596
[TBL] [Abstract][Full Text] [Related]
18. Validation of an ultrasensitive and specific immunofluorometric assay for mouse follicle-stimulating hormone.
Jimenez M; Spaliviero JA; Grootenhuis AJ; Verhagen J; Allan CM; Handelsman DJ
Biol Reprod; 2005 Jan; 72(1):78-85. PubMed ID: 15342359
[TBL] [Abstract][Full Text] [Related]
19. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer.
Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Ohta Y; Watanabe G
Chest; 2004 Aug; 126(2):342-6. PubMed ID: 15302715
[TBL] [Abstract][Full Text] [Related]
20. Influence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer.
Du K; Gong HY; Gong ZM
Asian Pac J Cancer Prev; 2014; 15(20):8793-6. PubMed ID: 25374209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
